Á. Castel

Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.

J. Brugada, M. Sitges, L. Mont, 2009, The American journal of cardiology.

Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis.

X. Freixa, E. Guasch, D. Arzamendi, 2009, Transplantation proceedings.

Ventricular tachycardia and aggravation of Brugada ECG pattern in a patient with coronary artery disease and combined amiodarone and betablocker therapy

H. Nägele, S. Behrens, Á. Castel, 2008, Clinical Research in Cardiology.

Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.

M. Farrero, E. Roig, F. Pérez-Villa, 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors

J. Brugada, M. Sitges, R. Borrás, 2014, European journal of heart failure.

Fusion‐Optimized Intervals (FOI): A New Method to Achieve the Narrowest QRS for Optimization of the AV and VV Intervals in Patients Undergoing Cardiac Resynchronization Therapy

J. Brugada, M. Sitges, L. Mont, 2014, Journal of cardiovascular electrophysiology.

Optimization of the interventricular delay in cardiac resynchronization therapy using the QRS width.

D. Tamborero, J. Brugada, M. Sitges, 2009, The American journal of cardiology.

Cardiac Transplantation in Danon Disease.

P. García-Pavía, K. Hong, C. Díez-López, 2021, Journal of cardiac failure.

Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) a powerful predictor of long term mortality in patients treated with cardiac resynchronization therapy

J. Brugada, M. Sitges, M. Batlle, 2013 .